Clinical Trials

78 enrolled

Carcinoma, Renal Cell, Neoplasms

NCT06860386 2026-03-06

Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC

Phase 2 Suspended

75 enrolled

Carcinoma, Renal Cell

NCT01409200 2026-03-03

Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis

Phase 2 Not yet recruiting

73 enrolled

Lymphatic Metastasis

NCT07123090 2026-02-27

SPARCC

25 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT05327686 2026-01-14

SAMURAI

240 enrolled

Phase 2 Active not recruiting

Carcinoma, Renal Cell

NCT03092856 2025-12-17

Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer

62 enrolled

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07277972 2025-12-11

Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic Therapy

36 enrolled

Carcinoma, Renal Cell

NCT04996823 2025-12-04

Axitinib + Ipilimumab in Advanced Melanoma

25 enrolled

Dermatologic

Melanoma, Skin Neoplasms

NCT04370509 2025-11-19

Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery

Phase 2 Terminated

6 enrolled 11 charts

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT07172386 2025-09-16

Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC

40 enrolled

Carcinoma, Renal Cell

NCT04258956 2025-09-11

AXAGIST

Phase 2 Not yet recruiting

58 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT07159191 2025-09-08

Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma

Advanced Renal Cell Carcinoma (aRCC)

NCT04341181 2025-07-25

ProTarget

Phase 2 Active not recruiting

300 enrolled

Tumor-Agnostic

Neoplasms

NCT02912572 2025-07-10

Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer

106 enrolled 16 charts

Gynecologic

Endometrial Neoplasms

NCT02597322 2025-04-06

AXIPAN

21 enrolled

cT2a N0NxM0 Renal Tumor

NCT05969496 2025-04-04

NEOPAX

17 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06889649 2025-03-21

SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC

Radiation Therapy

NCT04562441 2025-01-10

NPC - AXEL Study : Axitinib-Avelumab

13 enrolled

Recurrence

NCT06211114 2024-11-26

Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma

Carcinoma, Renal Cell

NCT01693822 2024-11-21

A-PREDICT

65 enrolled 15 charts

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT06690697 2024-11-15

Combination of Toripalimab and JS004 Therapy for ccRCC

80 enrolled

Carcinoma, Renal Cell

NCT01263769 2024-09-19

Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC)

39 enrolled 6 charts

Kidney Neoplasms

NCT02636725 2024-07-12

Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas

33 enrolled 14 charts

Sarcoma

Sarcoma, Sarcoma, Alveolar Soft Part

NCT02579811 2023-06-29

Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer

40 enrolled 12 charts

Carcinoma, Renal Cell, Neoplasms

NCT05817903 2023-05-08

AxIn

118 enrolled

Carcinoma, Renal Cell

NCT05249569 2023-05-03

Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma

Phase 2 Terminated

1 enrolled 4 charts

Carcinoma, Hepatocellular

NCT04010071 2023-03-29

Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors

60 enrolled

Biliary Tract Neoplasms, Liver Neoplasms

NCT01385059 2023-03-07

Axitinib Before Surgery in Treating Patients With High-Risk Prostate Cancer

11 enrolled 10 charts

Prostatic Neoplasms

NCT02489695 2022-09-06

AXIPAP

44 enrolled

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT05263609 2022-08-02

Optimizing Pembrolizumab Therapy With Timing and Intensification With Axitinib

Phase 2 Withdrawn

Carcinoma, Renal Cell

NCT02129647 2021-12-01

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

13 enrolled 7 charts

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT02261207 2021-09-28

Phase II Study on Axitinib in Advanced Solitary Fibrous Tumor

17 enrolled

Solitary Fibrous Tumors

NCT01649180 2021-08-12

PrE0801

Phase 2 Terminated

3 enrolled 7 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04995016 2021-08-06

PANDORA

18 enrolled

Carcinoma, Renal Cell

NCT04958473 2021-07-12

SAARCC

40 enrolled

Carcinoma, Renal Cell

NCT03494816 2021-06-30

NAXIVA

24 enrolled 11 charts

Carcinoma, Renal Cell

NCT02762513 2021-05-05

Expansion Trial for Axitinib In Head And Neck Cancer

29 enrolled 18 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT01140737 2021-03-18

Axi-STS

145 enrolled

Sarcoma

NCT01321437 2021-01-20

Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma

11 enrolled 12 charts

Dermatologic

Melanoma

NCT04698213 2021-01-06

TIDE-A

75 enrolled

Tumor-Agnostic

Carcinoma, Neoplasm Metastasis

NCT01798446 2020-12-08

A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus

41 enrolled

Carcinoma, Renal Cell

NCT04197219 2020-11-05

Pembrolizumab With Axitinib in Recurrent Endometrial Cancer

Phase 2 Withdrawn

Gynecologic

Endometrial Neoplasms

NCT04459663 2020-07-07

JS001 Combination Therapy in NSCLC Negative Driving Gene After First-line Chemotherapy.

50 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04385654 2020-05-13

Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma

40 enrolled

Kidney Neoplasms, Neoplasm Metastasis

NCT04355156 2020-04-21

AXMUS-C

52 enrolled

Colorectal Neoplasms

NCT02638428 2020-03-19

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

90 enrolled

Other solid neoplasm

Relapsed Pediatric Solid Tumor

NCT01334112 2019-12-12

AXITINIB

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01490866 2019-09-24

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

70 enrolled 9 charts

Colorectal Neoplasms

NCT02857712 2019-08-30

SGC-AX14

26 enrolled

Head & Neck

Salivary Gland Neoplasms

NCT01562197 2019-01-24

AxiGII